Vitamin B-12, Folic Acid, and Growth in 6- to 30-Month-Old Children: A Randomized Controlled Trial
Citations:61
Influential Citations:3
Interventional (Human) Studies
82
Enhanced Details
Methods
Randomized, placebo-controlled trial in North Indian children aged 6 to 30 months from urban communities in New Delhi. Active intervention groups included vitamin B-12 (n=252), folate (n=249), and vitamin B-12 plus folate (n=250), with 1:1:1:1 allocation across four arms and follow-up for 6 months.
Intervention
Children were randomized to one of three daily oral paste supplements for 6 months: vitamin B-12 (1.8 µg per 10 g), folic acid (150 µg per 10 g), or vitamin B-12 plus folic acid (1.8 µg vitamin B-12 plus 150 µg folic acid per 10 g). Children aged 6-11 months received 5 g daily, and those older than 12 months received 10 g daily; the paste was administered at home by a field worker, with caregiver administration on Sundays and holidays.
Results
Overall, supplementation produced modest growth benefits, with the clearest signal for vitamin B-12 and the combined vitamin B-12 plus folate regimen. Vitamin B-12 increased weight change slightly versus placebo (1.09 kg vs 1.03 kg; mean difference 0.06, 95% CI -0.01 to 0.13) and improved WAZ change (0.02 vs -0.05; mean difference 0.07, 95% CI 0.01 to 0.13). Folic acid showed a small, non-significant increase in length/height change versus placebo (5.46 cm vs 5.26 cm; mean difference 0.20, 95% CI -0.03 to 0.44), while the combination group had a weight increase of 120 g (95% CI 3 to 210 g) and a length increase of 0.35 cm (95% CI 0.0 to 0.66 cm). Authors concluded that poor vitamin B-12 and folate status contribute to poor growth, but that the effects were modest and likely require higher doses and longer follow-up for confirmation.
Limitations
Effects were small and some primary comparisons were not statistically significant, limiting certainty about clinical importance. Follow-up was only 6 months, and adverse events were not reported. Generalizability is limited to young urban North Indian children with substantial baseline malnutrition and micronutrient deficiency risk, and subgroup benefits may not apply broadly.
Abstract
BACKGROUND: Folate and vitamin B-12 are important for growth. Many children in low- and middle-income countries have inadequate intakes of these nutrients. METHODS: We undertook a randomized, placebo controlled double-blind trial in 1000 North Indian...